Tourmaline Bio Inc.
10/10/2024 | Press release | Distributed by Public on 10/10/2024 14:26
Management Change/Compensation Form 8 K
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On October 4, 2024, Dr. Yung Chyung gave notice of his decision to resign from his position as Chief Medical Officer of Tourmaline Bio, Inc. (the "Company") in order to pursue another opportunity. His resignation will be effective on October 31, 2024. Dr. Chyung will continue to serve as Chief Medical Officer through October 31, 2024, to assist with an orderly transition as his duties are assumed by other members of the senior management team. Dr. Chyung has served as the Company's Chief Medical Officer since August 2022, and the Company extends its gratitude to Dr. Chyung for his years of service and contributions to the Company. The Company has initiated a process to identify a successor. Dr. Chyung's decision to resign was not due to any disagreement with the Company on any matter, or relating to its operations, policies, or practices.